학술논문
A Case Series of Minimally Invasive Robotic-Assisted Resection of Cardiac Papillary Fibroelastoma: The Mayo Clinic Experience.
Document Type
Academic Journal
Author
Ahmad A; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN.; El-Am EA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.; Mazur P; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN.; Akiki E; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.; Sorour AA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.; Kurmann RD; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.; Klarich KW; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.; Arghami A; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN.; Rowse PG; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN.; Daly RC; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN.; Dearani JA; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN.
Source
Publisher: Elsevier Inc Country of Publication: Netherlands NLM ID: 101728275 Publication Model: eCollection Cited Medium: Internet ISSN: 2542-4548 (Electronic) Linking ISSN: 25424548 NLM ISO Abbreviation: Mayo Clin Proc Innov Qual Outcomes Subsets: PubMed not MEDLINE
Subject
Language
English
Abstract
Papillary fibroelastomas (PFEs) are small, slowly growing benign cardiac tumors with clinically significant risk of embolization. Surgical excision is the definitive treatment of symptomatic PFE and is conventionally performed through a median sternotomy. In this study, we report a series of 12 patients, who underwent robotic-assisted PFE removal at the Mayo Clinic. PFE involved the mitral valve, left atrium, and tricuspid valve. No major complications occurred after the procedure, and most patients were discharged 4 days after the surgery. On follow-up, 1 patient demonstrated pericarditis.
Competing Interests: The authors declare no conflicts of interest.
(© 2024 The Authors.)
Competing Interests: The authors declare no conflicts of interest.
(© 2024 The Authors.)